Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Viking Therapeutics announced the initiation of a phase 2 clinical trial of the oral tablet formulation of its dual GLP-1/GIP receptor agonist, VK2735.
read more
The star of the deal is Intra-Cellular's FDA-approved and potential blockbuster drug, Caplyta.
read more
Gilead looks to use the STAT6 pathway to develop an oral option for patients suffering from chronic inflammatory conditions.
read more
LNK International is recalling a batch of Kirkland branded cold and flu capsules after shipping potentially contaminated product.
read more
The global pharmaceutical and nutraceutical excipient manufacturer has appointed Sven Abend as the company’s new CEO.
read more
Iclepertin, a once-daily oral treatment for cognitive impairment in schizophrenia, failed to best a placebo in a series of three trials.
read more
Calquence is the first and only BTK inhibitor approved for the first-line treatment of MCL in the U.S.
read more
Trial data shows potential for the treatment regimen to become the new standard of care for BRAF V600E-mutant metastatic colorectal cancer.
read more
Israel-based gummy supplements provider snaps up the Canadian CDMO Island Abbey in a deal worth over $20 million.
read more
Sage’s Board says the $469 million proposal “significantly undervalues Sage” and is not in the best interest of shareholders.
read more
Pfizer will pony up close to $60 million to resolve Biohaven's bogus speaker program headache.
read more
Journavx tablets provide effective pain relief without the addictive potential of opioids.
read more
The CDMO will manufacture clinical batches of Jotrol, Jupiter’s proprietary resveratrol-based therapeutic, using an optimized softgel formulation.
read more
Bangladesh-based conglomerate Advanced Chemical Industries plans to introduce a new subsidiary, ACI Herbal and Nutraceuticals.
read more
The Belgian CDMO will take ownership of the 50,000-square-foot CGMP facility in Somerset, New Jersey, and will add a new bioanalytical lab.
read more